🇺🇸 FDA
Pipeline program

Group A (clinical guideline+machine learning)

NCRCSZ-2023-014

Unknown other active

Quick answer

Group A (clinical guideline+machine learning) for Hypertension is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Hypertension
Phase
Unknown
Modality
other
Status
active

Clinical trials